Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial

Mulders, P.F.A.; Martinez-Pineiro, L.; Heidenreich, A.; Babjuk, M.; Colombel, Marc; Colombo, R.; Witjes, W.P.J.; Komyakov, B.; Steen, Peter Van den

Fulltext:

208962.pdf

Embargo:

until further notice

Size:

401.5Kb

Format:

PDF

Description:

Publisher’s version

Publication year

2019

Author(s)

Source

European Urology Focus, 5, 5, (2019), pp. 849-852

ISSN

2405-4569

DOI

https://doi.org/10.1016/j.euf.2018.02.005

Publication type

Article / Letter to editor

Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/208962

Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.

Radboud Repository

Radboud Repository

Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial

Publication year

Author(s)

Source

ISSN

DOI

Publication type

Organization

Journal title

Volume

Issue

Page start

Page end

Subject

This item appears in the following Collection(s)